BAA FY26C1CP12: FDA, center for devices and radiological health (CDRH), estimation of in-vivo tissue properties using clinical MR thermometry data
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00056
- Awardee
-
The Research Foundation For The State University Of New York UEI NQMVAAQUFU53 Part of The Research Foundation For The State University Of New York
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,456,000
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 100% obligated
- $2,456,000.00 Current and potential, with all options
- Completion date 3% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 253 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Binghamton, NY 13902, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a firm-fixed-price definitive contract with a $2.456 million ceiling to The Research Foundation For The State University Of New York, doing business as SUNY at Binghamton, for estimation of in-vivo tissue properties using clinical MR thermometry data, on September 30, 2026. No set-aside was used. The award runs from September 30, 2026 through September 29, 2029, with place of performance in Binghamton, New York 13902.
The FDA Center for Devices and Radiological Health (CDRH) placed the award under BAA FY26C1CP12, the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, issued by the FDA Office of Acquisition and Grant Services. The BAA solicits basic and applied research across three charge areas: modernizing development and evaluation of FDA-regulated products, strengthening post-market surveillance and labeling, and invigorating public health preparedness and response. Research priority areas include new approach methodologies, advanced manufacturing, analytical and computational methods, biomarkers, clinical outcome assessments, and emerging technologies. The solicitation is classified under NAICS 541714 and PSC AJ11. It was posted November 21, 2025 as a Special Notice, used a two-stage submission process with Stage One packages due February 24, 2026, and was amended through January 16, 2026. The FDA held a virtual BAA day on January 20, 2026. Academic institutions were eligible offerors, and small businesses were strongly encouraged to participate.
Quick answers
Who was awarded contract 75F40126C00056?
75F40126C00056 was awarded to The Research Foundation For The State University Of New York by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00056 worth?
The government has obligated $2,456,000 on 75F40126C00056.
Was contract 75F40126C00056 competed?
The extent of competition for 75F40126C00056 was full and open competition. The government received 253 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award